AU2003291457A1 - Pharmaceutical antiviral compositions - Google Patents
Pharmaceutical antiviral compositionsInfo
- Publication number
- AU2003291457A1 AU2003291457A1 AU2003291457A AU2003291457A AU2003291457A1 AU 2003291457 A1 AU2003291457 A1 AU 2003291457A1 AU 2003291457 A AU2003291457 A AU 2003291457A AU 2003291457 A AU2003291457 A AU 2003291457A AU 2003291457 A1 AU2003291457 A1 AU 2003291457A1
- Authority
- AU
- Australia
- Prior art keywords
- antiviral compositions
- pharmaceutical antiviral
- pharmaceutical
- compositions
- oxathiolan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- JTEGQNOMFQHVDC-NKWVEPMBSA-N lamivudine Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1 JTEGQNOMFQHVDC-NKWVEPMBSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42518202P | 2002-11-08 | 2002-11-08 | |
| US60/425,182 | 2002-11-08 | ||
| PCT/US2003/035830 WO2004043433A2 (en) | 2002-11-08 | 2003-11-07 | Pharmaceutical antiviral compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003291457A8 AU2003291457A8 (en) | 2004-06-03 |
| AU2003291457A1 true AU2003291457A1 (en) | 2004-06-03 |
Family
ID=32312939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003291457A Abandoned AU2003291457A1 (en) | 2002-11-08 | 2003-11-07 | Pharmaceutical antiviral compositions |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20050287177A1 (https=) |
| EP (1) | EP1567133B1 (https=) |
| JP (1) | JP2006508134A (https=) |
| AT (1) | ATE361059T1 (https=) |
| AU (1) | AU2003291457A1 (https=) |
| CA (1) | CA2505130C (https=) |
| DE (1) | DE60313657T2 (https=) |
| ES (1) | ES2286471T3 (https=) |
| WO (1) | WO2004043433A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY169670A (en) | 2003-09-03 | 2019-05-08 | Tibotec Pharm Ltd | Combinations of a pyrimidine containing nnrti with rt inhibitors |
| ES2320663T3 (es) | 2003-08-26 | 2009-05-27 | Smithkline Beecham Corporation | Nuevos indoles cicloalquil(b) condensados. |
| TW201414495A (zh) | 2005-04-04 | 2014-04-16 | Tibotec Pharm Ltd | Ｈｉｖ-感染之預防 |
| RU2008128424A (ru) * | 2005-12-14 | 2010-01-20 | Сипла Лимитед (In) | Фармацевтическая комбинация, включающая нуклеотидный и нуклеозидный ингибиторы обратной транскриптазы (такие как тенофовир и ламивудин) в различных частях дозы |
| PT1981506E (pt) | 2006-01-20 | 2013-06-25 | Janssen R & D Ireland | Tratamento a longo prazo da infeção pelo vih com tmc278 |
| AR065720A1 (es) | 2007-03-14 | 2009-06-24 | Tibotec Pharm Ltd | Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso. |
| JP2010529073A (ja) * | 2007-06-06 | 2010-08-26 | ビーエーエスエフ ソシエタス・ヨーロピア | チュアブル錠及びトローチ剤製造のための医薬製剤 |
| MX2009013063A (es) * | 2007-06-06 | 2010-01-15 | Basf Se | Formulacion farmaceutica para la produccion de tabletas de desintegracion rapida. |
| MX2009013499A (es) * | 2007-06-22 | 2010-01-18 | Bristol Myers Squibb Co | Composiciones comprimidas que contienen atazanavir. |
| KR101057640B1 (ko) * | 2009-05-27 | 2011-08-18 | (주)다산메디켐 | 발포성 층을 포함하는 다층 정제 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4724232A (en) * | 1985-03-16 | 1988-02-09 | Burroughs Wellcome Co. | Treatment of human viral infections |
| GB8707421D0 (en) * | 1987-03-27 | 1987-04-29 | Wellcome Found | Pharmaceutical formulations |
| US5047407A (en) * | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
| US5009895A (en) * | 1990-02-02 | 1991-04-23 | Merck & Co., Inc. | Sustained release with high and low viscosity HPMC |
| GB9009861D0 (en) * | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
| WO1992020344A1 (en) * | 1991-05-16 | 1992-11-26 | Glaxo Group Limited | Antiviral combinations containing nucleoside analogs |
| GB9111902D0 (en) * | 1991-06-03 | 1991-07-24 | Glaxo Group Ltd | Chemical compounds |
| US6177435B1 (en) * | 1992-05-13 | 2001-01-23 | Glaxo Wellcome Inc. | Therapeutic combinations |
| ATE186544T1 (de) * | 1992-08-04 | 1999-11-15 | James M Dunn | Pharmazeutische formulierungen mit kontrollierter freigabe von 3'-azido-3'-deoxythymidin und verfahren zur verwendung |
| US6113920A (en) * | 1996-10-31 | 2000-09-05 | Glaxo Wellcome Inc. | Pharmaceutical compositions |
| GB9622681D0 (en) * | 1996-10-31 | 1997-01-08 | Glaxo Group Ltd | Pharmaceutical compositions |
| US6541014B2 (en) * | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
-
2003
- 2003-11-07 JP JP2004552010A patent/JP2006508134A/ja active Pending
- 2003-11-07 US US10/533,325 patent/US20050287177A1/en not_active Abandoned
- 2003-11-07 CA CA002505130A patent/CA2505130C/en not_active Expired - Fee Related
- 2003-11-07 AT AT03768857T patent/ATE361059T1/de not_active IP Right Cessation
- 2003-11-07 EP EP03768857A patent/EP1567133B1/en not_active Expired - Lifetime
- 2003-11-07 DE DE60313657T patent/DE60313657T2/de not_active Expired - Lifetime
- 2003-11-07 WO PCT/US2003/035830 patent/WO2004043433A2/en not_active Ceased
- 2003-11-07 AU AU2003291457A patent/AU2003291457A1/en not_active Abandoned
- 2003-11-07 ES ES03768857T patent/ES2286471T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1567133B1 (en) | 2007-05-02 |
| DE60313657T2 (de) | 2008-01-03 |
| CA2505130A1 (en) | 2004-05-27 |
| ES2286471T3 (es) | 2007-12-01 |
| AU2003291457A8 (en) | 2004-06-03 |
| EP1567133A2 (en) | 2005-08-31 |
| ATE361059T1 (de) | 2007-05-15 |
| US20050287177A1 (en) | 2005-12-29 |
| DE60313657D1 (de) | 2007-06-14 |
| CA2505130C (en) | 2009-10-06 |
| WO2004043433A3 (en) | 2004-12-29 |
| JP2006508134A (ja) | 2006-03-09 |
| WO2004043433A2 (en) | 2004-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW366346B (en) | 1,3-oxathiolane nucleoside analogue | |
| AU2003291726A8 (en) | Gemcitabine prodrugs, pharmaceutical compositions and uses thereof | |
| NZ306419A (en) | Synergistic combinations of 1592U89, 3TC and optionally zidovudine or 1592U89, FTC and zidovudine | |
| PL398295A1 (pl) | Analogi nukleozydów przeciwwirusowych, zawierająca je kompozycja farmaceutyczna i ich zastosowania | |
| AU2003291457A1 (en) | Pharmaceutical antiviral compositions | |
| GR1005052B (el) | Συνθεσεις περιεχουσες αγωνιστη υποδοχεων s1p | |
| WO2004078105A3 (fr) | Composition de fondaparinux sodique de haute purete | |
| BR0311327A (pt) | Composição farmacêutica contendo oxcarbazepina com liberação sustentada de um ingrediente ativo | |
| YU47799A (sh) | Farmaceutski preparati | |
| BRPI0313645A2 (pt) | composições de inalação com relações de droga elevadas. | |
| TW200509794A (en) | Novel anthelmintic and insecticidal compositions | |
| JP2006508134A5 (https=) | ||
| PL376148A1 (en) | Vitamin d analogues, compositions comprising said analogues and their use | |
| NO20065791L (no) | Asyklovir-formuleringer | |
| AU2003244259A1 (en) | Oral injectable pharmaceutical composition comprising florfenicol as an active ingredient | |
| WO2000018383A3 (en) | Antiviral combinations comprising (s)-2- ethyl-7- fluoro-3- oxo-3,4- dihydro-2h- quinoxaline-1- carboxylic acid isopropyl ester | |
| WO2001030329A3 (en) | Combinations of lamivudine and entecavir for treatment of hepatitis b virus infuction | |
| ATE162401T1 (de) | Antivitale zusammensetzungen | |
| ECSP982450A (es) | Composiciones farmaceuticas | |
| HK40093983A (en) | 1'-cyano nucleoside analogs and uses thereof | |
| HK1103031A (en) | Pharmaceutical formulations cytidine analogs and derivatives | |
| EP1444521A4 (en) | METHODS AND COMPOSITIONS INVOLVING THYMIDINPHOSPHORYLASE AS A MARKER FOR HIV INFECTION, THE COURSE OF AIDS AND DRUG RESISTANCE | |
| ATE429905T1 (de) | Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung | |
| WO2002070070A3 (en) | Compositions having improved bioavailability of eletriptan | |
| IL183927A0 (en) | Sulfonyl amino cyclic derivatives, their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase | ||
| TH | Corrigenda |
Free format text: IN VOL 18, NO 26, PAGE(S) 7166 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME GLAXOGROUP LIMITED, APPLICATION NO. 2003291457, UNDER INID (71) CORRECT THE NAME TO READ SMITHKLINE BEECHAM CORPORATION; GLAXO GROUP LIMITED |